The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
Yang, Chin-An, Bauer, Sandra, Ho, Yu-Chen et al. · Journal of translational medicine · 2018 · DOI
Quick Summary
Researchers looked at special molecules called very long non-coding RNAs in the blood of ME/CFS patients to see if they might be disease markers. They found that three of these RNA molecules (NTT, MIAT, and EmX2OS) were present at higher levels in ME/CFS patients compared to healthy people, and two of them (NTT and EmX2OS) increased with disease severity. When they tested these findings in lab cells exposed to oxidative stress and viral signals, the RNA levels increased, suggesting these molecules respond to the kinds of biological stresses that may occur in ME/CFS.
Why It Matters
Identifying disease-associated molecular signatures is crucial for developing diagnostic tests and understanding ME/CFS mechanisms. This study provides evidence that specific non-coding RNAs may reflect the biological dysregulation—oxidative stress, immune activation, and metabolic impairment—proposed to underlie ME/CFS, potentially opening new avenues for biomarker development and therapeutic intervention.
Observed Findings
Three lncRNAs (NTT, MIAT, EmX2OS) were significantly elevated in ME/CFS patients compared to healthy controls.
NTT and EmX2OS expression levels increased with disease severity.
Oxidative stress (H₂O₂) stimulation increased NTT and MIAT expression in human cell lines.
Viral mimic (poly I:C) stimulation increased NTT and MIAT expression in human cell lines.
Expression changes in cell models suggest these lncRNAs respond to oxidative stress and viral activation signals.
Inferred Conclusions
ME/CFS is characterized by a distinct very long lncRNA expression signature that may reflect dysregulated responses to oxidative stress, chronic viral infection, and metabolic stress.
The lncRNAs NTT, MIAT, and EmX2OS are potential biological markers that could aid in ME/CFS diagnosis and severity assessment.
These lncRNAs may serve as molecular indicators of the pathobiological processes—including oxidative stress and immune dysregulation—implicated in ME/CFS pathogenesis.
Remaining Questions
What are the specific molecular and cellular functions of NTT, MIAT, and EmX2OS in ME/CFS pathogenesis?
Can these lncRNA expression levels reliably discriminate ME/CFS patients from other conditions with similar symptoms (e.g., other fatiguing illnesses)?
What This Study Does Not Prove
This study does not establish that these lncRNAs cause ME/CFS or prove their specific functional roles in disease pathogenesis. The findings are correlative and based on a small patient cohort; the in vitro cell experiments, while suggestive, do not definitively demonstrate that the same mechanisms operate in living ME/CFS patients. Larger validation studies and functional characterization are needed before these markers could be used clinically.